Выбор редакции

Meta-Analysis Finds Benefits for Self-Monitoring in Some Warfarin Patients

Despite the advent of newer anticoagulants that don?t require monitoring, millions of people will continue to take warfarin for many years to come. Now a new meta-analysis published in the Lancet suggests that some of these patients may benefit from self-monitoring. Carl Heneghan and colleagues analyzed data from 11 trials with 6,417 participants and 12,800 ...